Post A Reply

Rate Johnson & Johnson

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment

×

Salaries

In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position

Compensation

* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.

×

Hot Ticker Articles

Diversified growth lifts Boston Scientific in Q1

Mazor Robotics Q1 2018 Investor Presentation

Intuitive Surgical hits 2018 priorities. Blows past Q1 expectations

Johnson & Johnson medical device business delivers 7.5% growth in Q1

Boston Scientific marketing gets innovative with new video series

Job Listings

J&J Layoffs

CSS doesn't fit into the long-term strategy of where J&J is going in terms of maintaining at least 4% growth. There will have to be more than just layoffs in order for J&J to fix what's broken here. BWI is a keeper for J&J, and BWI is already physically separate from the rest of CSS with their own buildings and campus in Irwindale & Israel. Mentor could easily be sold off or spun back off into an independent company as they were before 2009 since they have their own buildings and campuses in Texas and Netherlands. ASP, Sterilmed and Acclarent could be sold off to a private equity firm like Ortho Clinical Diagnostics was. In order to sell ASP, Sterilmed and Acclarent, they would need to cut headcount and outsource most manufacturing. A good chunk of Sterilmed's operations are outsourced to outside vendors or contractors, ASP's manufacturing is nearly all outsourced, and all of Acclarent's manufacturing is outsourced. With a few more layoffs here and there, the pieces are already in place for J&J to break up CSS.

Post A Reply

Report this entire thread

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a thread a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the thread has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.

Ok, scary, but all valid points, but we've heard rumors about being sold off for over a year and still nothing. Are there new rumblings of Acclarent and Sterilmed being sold off?

Acclarent was rumored to have interest from Olympus but sounds like they were both far apart on price.

post

Ok, scary, but all valid points, but we've heard rumors about being sold off for over a year and still nothing. Are there new rumblings of Acclarent and Sterilmed being sold off?

post

Sterilmed reprocesses all the used products for BWI, Ethicon, & DePuy Synthes, keeping them alive. J&J is keeping Sterilmed for that reason only.

Exactly the truth. The alternative would be giving Stryker Sustainability all of that business which is the last thing JNJ needs right now.

post

I'm perplexed why Sterilmed won't be sold off.

Sterilmed reprocesses all the used products for BWI, Ethicon, & DePuy Synthes, keeping them alive. J&J is keeping Sterilmed for that reason only.

post

CSS has been split up for a sale, along with the Power Tools unit of Synthes. The new CSS is keeping BWI, Cerenovus, and Sterilmed. Acclarent, ASP, and Mentor along with Synthes-Power Tools are up for sale and are now separated from CSS.

I'm perplexed why Sterilmed won't be sold off.

post

Any reorgs coming in the ethicon/Device side coming down the pike? Layoffs?

CSS has been split up for a sale, along with the Power Tools unit of Synthes. The new CSS is keeping BWI, Cerenovus, and Sterilmed. Acclarent, ASP, and Mentor along with Synthes-Power Tools are up for sale and are now separated from CSS.

post

Inept leadership ..... its only a matter of time until CSS is no longer. Even BWI has started to lose market share so JnJ will milk this business for a few more years and probably toss it aside (y'all remember Cordis). JnJ's long term prospect is in pharmaceuticals.

Any reorgs coming in the ethicon/Device side coming down the pike? Layoffs?

post

Hopefully the Gorsk can toss Celine's boyfriend SN in the next round also

Canadian layoffs in Q1 is the current talk. Others hear this?

post

Hopefully the Gorsk can toss Celine's boyfriend SN in the next round also

What Celine are you talking about?

post

You think Gorsky could fit Celine into the next round?

Hopefully the Gorsk can toss Celine's boyfriend SN in the next round also

post

You think Gorsky could fit Celine into the next round?

post

This shouldn't be a surprise but 34 people are being let go starting March 9th in West Chester and Wayne due to a closure.

post

Did J&J close down the DePuy site in Warsaw already?

Uhh, no.

post

Did J&J close down the DePuy site in Warsaw already?

post

Loading...


Load More

Report this post

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a post a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the post has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.